SEC 13F Intelligence

Rtw Investments, LP / TSHA

Rtw Investments, LP’s Taysha Gene Therapies Inc Position

Does Rtw Investments, LP own Taysha Gene Therapies Inc (TSHA)? Yes — 13.68M shares worth $61M (+0.61% of its 13F portfolio) as of Q1 2026, down from 16.40M shares the prior filed quarter.

Position Value
$61M
Q1 2026
Shares
13.68M
% of Portfolio
+0.61%
Quarters Held
11
currently held

Position History TSHA

Reported value by quarter
Q3 ’23: $53MQ3 ’23Q4 ’23: $30MQ1 ’24: $53MQ1 ’24Q2 ’24: $42MQ3 ’24: $30MQ3 ’24Q4 ’24: $15MQ1 ’25: $26MQ1 ’25Q2 ’25: $58MQ3 ’25: $80MQ3 ’25Q4 ’25: $90MQ1 ’26: $61MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202613.68M$61M+0.61%
Q4 202516.40M$90M+0.90%
Q3 202524.35M$80M+0.98%
Q2 202525.02M$58M+0.82%
Q1 202518.79M$26M+0.40%
Q4 20248.67M$15M+0.23%
Q3 202414.95M$30M+0.43%
Q2 202418.80M$42M+0.65%
Q1 202418.59M$53M+0.79%
Q4 202316.89M$30M+0.47%
Q3 202316.89M$53M+1.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of TSHA.